Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Shareholders' Equity (Deficit) (Unaudited)

v3.22.2.2
Condensed Consolidated Statements of Shareholders' Equity (Deficit) (Unaudited) - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Treasury Stock [Member]
Total
Beginning balance, value at Dec. 31, 2020 $ 4,719 $ 14,553,438 $ (21,964,321) $ (7,406,164)
Beginning balance, shares at Dec. 31, 2020 4,718,714        
Stock-based compensation 1,096,441 1,096,441
Net income (loss) (271,482) (271,482)
Stock issuance related to acquisition $ 202 1,999,798 2,000,000
Stock Issuance related to acquisition, shares 202,066        
Stock issued with exercise of warrants $ 22 9,974 9,996
Stock issued with exercise of warrants, shares 22,490        
Common stock repurchased (6,901,811) (6,901,811)
Stock Options Exercised $ 38 235,187 235,225
Stock Options Exercised, shares 37,882        
Beneficial conversion feature 636,075 636,075
Conversion of Bridge Financing $ 254 1,907,971 1,908,225
Conversion of Bridge Financing, shares 254,425        
Stock grant program vesting $ 85 (85)
Stock grant program vesting, shares 85,267        
Stock issuance related to offering, net of offering costs of $4,596,257 $ 6,210 57,497,533 57,503,743
Stock issuance related to offering, net of offering costs of $4,596,257, shares 6,210,000        
Ending balance, value at Sep. 30, 2021 $ 11,530 77,936,332 (22,235,803) (6,901,811) 48,810,248
Beginning balance, shares at Sep. 30, 2021 11,530,844        
Beginning balance, value at Jun. 30, 2021 $ 11,223 75,227,775 (22,295,459) (3,474,270) 49,469,269
Beginning balance, shares at Jun. 30, 2021 11,222,914        
Stock-based compensation 506,034 506,034
Stock grant program vesting $ 68 (68)
Stock grant program vesting, shares 68,681        
Net income (loss) 59,656 59,656
Stock issuance related to acquisition $ 202 1,999,798 2,000,000
Stock Issuance related to acquisition, shares 202,066        
Stock issued with exercise of warrants $ 4 (4)
Stock issued with exercise of warrants, shares         4,078
Common stock repurchased (3,427,541) $ (3,427,541)
Stock Options Exercised $ 33 202,797 202,830
Stock Options Exercised, shares 33,105        
Ending balance, value at Sep. 30, 2021 $ 11,530 77,936,332 (22,235,803) (6,901,811) 48,810,248
Beginning balance, shares at Sep. 30, 2021 11,530,844        
Beginning balance, value at Dec. 31, 2021 $ 11,588 78,679,220 (22,839,988) (7,683,490) 48,167,330
Beginning balance, shares at Dec. 31, 2021 11,588,110        
Stock-based compensation 1,860,767 1,860,767
Treasury stock (3,956,447) (3,956,447)
Net income (loss) (11,096,304) (11,096,304)
Stock issuance related to acquisition $ 283 2,499,717 2,500,000
Stock Issuance related to acquisition, shares 283,515        
Stock issued with exercise of warrants $ 35 (35)
Stock issued with exercise of warrants, shares 34,863        
Stock Options Exercised $ 5 28,792 $ 28,797
Stock Options Exercised, shares 4,555       4,555
Stock grant program vesting $ 38 (38)
Stock issuance, shares 37,675        
Stock grant program vesting, shares         76,246
Ending balance, value at Sep. 30, 2022 $ 11,949 83,068,423 (33,936,292) (11,639,937) $ 37,504,143
Beginning balance, shares at Sep. 30, 2022 11,948,718        
Beginning balance, value at Jun. 30, 2022 $ 11,911 82,971,694 (25,275,509) (11,456,667) 46,251,429
Beginning balance, shares at Jun. 30, 2022 11,911,043        
Stock-based compensation 96,767 96,767
Treasury stock (183,270) (183,270)
Stock grant program vesting $ 38 (38)
Stock grant program vesting, shares 37,675        
Net income (loss) (8,660,783) (8,660,783)
Ending balance, value at Sep. 30, 2022 $ 11,949 $ 83,068,423 $ (33,936,292) $ (11,639,937) $ 37,504,143
Beginning balance, shares at Sep. 30, 2022 11,948,718